Home › Therapeutic areas › Ophthalmology › Dry Eye Disease
Dry Eye Disease (5 companies)
Companies with an active program in Dry Eye Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics | DermatologyOncology+1 | 1 | NDA Submitted | $38.3M | 5 |
| HROW | Harrow | Ophthalmology Rare | 2 | Approved | $1.01B | 15 |
| OCS | Oculis Holding | NeurologyOphthalmology Rare | 1 | Phase 3 | $417M | 5 |
| PTN | Palatin Technologies | ImmunologyMetabolic+1 Rare | 1 | Phase 3 | $11.2M | 8 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | $231M | 27 |
No companies match.